Target Gene/Pathway Pathway / Gene

  

Search results

No. KEGG PATHWAY
On map, Yellow: Drug target, Red: All disease-related 		KEGG GENES KEGG DRUG DrugBank Disease ID
1 Breast cancer 💬
 [1] FLT4 💬 Catequentinib 💬 Anlotinib [1] 85 💬
2 Breast cancer 💬
 [1] FLT4 💬 Axitinib 💬 Axitinib [1] 34 💬
3 Breast cancer 💬
 [1] FLT4 💬 Cediranib 💬 Cediranib [1] 34 💬
4 Breast cancer 💬
 [1] FLT4 💬 Cediranib maleate 💬 Cediranib [1] 34 💬
5 Breast cancer 💬
 [1] FLT4 💬 Nintedanib esylate 💬 Nintedanib [7] 51, 84, 85, 89, 227, 228, 331 💬
6 Breast cancer 💬
 [1] FLT4 💬 Nintedanib 💬 Nintedanib [7] 51, 84, 85, 89, 227, 228, 331 💬
7 Breast cancer 💬
 [1] FLT4 💬 Pazopanib hydrochloride 💬 Pazopanib [1] 227 💬
8 Breast cancer 💬
 [1] FLT4 💬 Sorafenib tosylate 💬 Sorafenib [2] 34, 86 💬
9 Breast cancer 💬
 [1] FLT4 💬 Sorafenib 💬 Sorafenib [2] 34, 86 💬
10 Breast cancer 💬
 [1] FLT4 💬 Sunitinib malate 💬 Sunitinib [2] 28, 34 💬
11 Breast cancer 💬
 [1] FLT4 💬 Sunitinib 💬 Sunitinib [2] 28, 34 💬
12 Breast cancer 💬
 [1] FLT4 💬 Tesevatinib 💬 Tesevatinib [1] 67 💬
13 Cadherin signaling 💬
 [1] FLT4 💬 Catequentinib 💬 Anlotinib [1] 85 💬
14 Cadherin signaling 💬
 [1] FLT4 💬 Axitinib 💬 Axitinib [1] 34 💬
15 Cadherin signaling 💬
 [1] FLT4 💬 Cediranib 💬 Cediranib [1] 34 💬
16 Cadherin signaling 💬
 [1] FLT4 💬 Cediranib maleate 💬 Cediranib [1] 34 💬
17 Cadherin signaling 💬
 [1] FLT4 💬 Nintedanib esylate 💬 Nintedanib [7] 51, 84, 85, 89, 227, 228, 331 💬
18 Cadherin signaling 💬
 [1] FLT4 💬 Nintedanib 💬 Nintedanib [7] 51, 84, 85, 89, 227, 228, 331 💬
19 Cadherin signaling 💬
 [1] FLT4 💬 Pazopanib hydrochloride 💬 Pazopanib [1] 227 💬
20 Cadherin signaling 💬
 [1] FLT4 💬 Sorafenib tosylate 💬 Sorafenib [2] 34, 86 💬
21 Cadherin signaling 💬
 [1] FLT4 💬 Sorafenib 💬 Sorafenib [2] 34, 86 💬
22 Cadherin signaling 💬
 [1] FLT4 💬 Sunitinib malate 💬 Sunitinib [2] 28, 34 💬
23 Cadherin signaling 💬
 [1] FLT4 💬 Sunitinib 💬 Sunitinib [2] 28, 34 💬
24 Cadherin signaling 💬
 [1] FLT4 💬 Tesevatinib 💬 Tesevatinib [1] 67 💬
25 Calcium signaling pathway 💬
 [1] FLT4 💬 Catequentinib 💬 Anlotinib [1] 85 💬
26 Calcium signaling pathway 💬
 [1] FLT4 💬 Axitinib 💬 Axitinib [1] 34 💬
27 Calcium signaling pathway 💬
 [1] FLT4 💬 Cediranib 💬 Cediranib [1] 34 💬
28 Calcium signaling pathway 💬
 [1] FLT4 💬 Cediranib maleate 💬 Cediranib [1] 34 💬
29 Calcium signaling pathway 💬
 [1] FLT4 💬 Nintedanib esylate 💬 Nintedanib [7] 51, 84, 85, 89, 227, 228, 331 💬
30 Calcium signaling pathway 💬
 [1] FLT4 💬 Nintedanib 💬 Nintedanib [7] 51, 84, 85, 89, 227, 228, 331 💬
31 Calcium signaling pathway 💬
 [1] FLT4 💬 Pazopanib hydrochloride 💬 Pazopanib [1] 227 💬
32 Calcium signaling pathway 💬
 [1] FLT4 💬 Sorafenib tosylate 💬 Sorafenib [2] 34, 86 💬
33 Calcium signaling pathway 💬
 [1] FLT4 💬 Sorafenib 💬 Sorafenib [2] 34, 86 💬
34 Calcium signaling pathway 💬
 [1] FLT4 💬 Sunitinib malate 💬 Sunitinib [2] 28, 34 💬
35 Calcium signaling pathway 💬
 [1] FLT4 💬 Sunitinib 💬 Sunitinib [2] 28, 34 💬
36 Calcium signaling pathway 💬
 [1] FLT4 💬 Tesevatinib 💬 Tesevatinib [1] 67 💬
37 Focal adhesion 💬
 [1] FLT4 💬 Catequentinib 💬 Anlotinib [1] 85 💬
38 Focal adhesion 💬
 [1] FLT4 💬 Axitinib 💬 Axitinib [1] 34 💬
39 Focal adhesion 💬
 [1] FLT4 💬 Cediranib 💬 Cediranib [1] 34 💬
40 Focal adhesion 💬
 [1] FLT4 💬 Cediranib maleate 💬 Cediranib [1] 34 💬
41 Focal adhesion 💬
 [1] FLT4 💬 Nintedanib esylate 💬 Nintedanib [7] 51, 84, 85, 89, 227, 228, 331 💬
42 Focal adhesion 💬
 [1] FLT4 💬 Nintedanib 💬 Nintedanib [7] 51, 84, 85, 89, 227, 228, 331 💬
43 Focal adhesion 💬
 [1] FLT4 💬 Pazopanib hydrochloride 💬 Pazopanib [1] 227 💬
44 Focal adhesion 💬
 [1] FLT4 💬 Sorafenib tosylate 💬 Sorafenib [2] 34, 86 💬
45 Focal adhesion 💬
 [1] FLT4 💬 Sorafenib 💬 Sorafenib [2] 34, 86 💬
46 Focal adhesion 💬
 [1] FLT4 💬 Sunitinib malate 💬 Sunitinib [2] 28, 34 💬
47 Focal adhesion 💬
 [1] FLT4 💬 Sunitinib 💬 Sunitinib [2] 28, 34 💬
48 Focal adhesion 💬
 [1] FLT4 💬 Tesevatinib 💬 Tesevatinib [1] 67 💬
49 Integrin signaling 💬
 [1] FLT4 💬 Catequentinib 💬 Anlotinib [1] 85 💬
50 Integrin signaling 💬
 [1] FLT4 💬 Axitinib 💬 Axitinib [1] 34 💬
51 Integrin signaling 💬
 [1] FLT4 💬 Cediranib 💬 Cediranib [1] 34 💬
52 Integrin signaling 💬
 [1] FLT4 💬 Cediranib maleate 💬 Cediranib [1] 34 💬
53 Integrin signaling 💬
 [1] FLT4 💬 Nintedanib esylate 💬 Nintedanib [7] 51, 84, 85, 89, 227, 228, 331 💬
54 Integrin signaling 💬
 [1] FLT4 💬 Nintedanib 💬 Nintedanib [7] 51, 84, 85, 89, 227, 228, 331 💬
55 Integrin signaling 💬
 [1] FLT4 💬 Pazopanib hydrochloride 💬 Pazopanib [1] 227 💬
56 Integrin signaling 💬
 [1] FLT4 💬 Sorafenib tosylate 💬 Sorafenib [2] 34, 86 💬
57 Integrin signaling 💬
 [1] FLT4 💬 Sorafenib 💬 Sorafenib [2] 34, 86 💬
58 Integrin signaling 💬
 [1] FLT4 💬 Sunitinib malate 💬 Sunitinib [2] 28, 34 💬
59 Integrin signaling 💬
 [1] FLT4 💬 Sunitinib 💬 Sunitinib [2] 28, 34 💬
60 Integrin signaling 💬
 [1] FLT4 💬 Tesevatinib 💬 Tesevatinib [1] 67 💬
61 MAPK signaling pathway 💬
 [1] FLT4 💬 Catequentinib 💬 Anlotinib [1] 85 💬
62 MAPK signaling pathway 💬
 [1] FLT4 💬 Axitinib 💬 Axitinib [1] 34 💬
63 MAPK signaling pathway 💬
 [1] FLT4 💬 Cediranib 💬 Cediranib [1] 34 💬
64 MAPK signaling pathway 💬
 [1] FLT4 💬 Cediranib maleate 💬 Cediranib [1] 34 💬
65 MAPK signaling pathway 💬
 [1] FLT4 💬 Nintedanib esylate 💬 Nintedanib [7] 51, 84, 85, 89, 227, 228, 331 💬
66 MAPK signaling pathway 💬
 [1] FLT4 💬 Nintedanib 💬 Nintedanib [7] 51, 84, 85, 89, 227, 228, 331 💬
67 MAPK signaling pathway 💬
 [1] FLT4 💬 Pazopanib hydrochloride 💬 Pazopanib [1] 227 💬
68 MAPK signaling pathway 💬
 [1] FLT4 💬 Sorafenib tosylate 💬 Sorafenib [2] 34, 86 💬
69 MAPK signaling pathway 💬
 [1] FLT4 💬 Sorafenib 💬 Sorafenib [2] 34, 86 💬
70 MAPK signaling pathway 💬
 [1] FLT4 💬 Sunitinib malate 💬 Sunitinib [2] 28, 34 💬
71 MAPK signaling pathway 💬
 [1] FLT4 💬 Sunitinib 💬 Sunitinib [2] 28, 34 💬
72 MAPK signaling pathway 💬
 [1] FLT4 💬 Tesevatinib 💬 Tesevatinib [1] 67 💬
73 Pathways in cancer 💬
 [1] FLT4 💬 Catequentinib 💬 Anlotinib [1] 85 💬
74 Pathways in cancer 💬
 [1] FLT4 💬 Axitinib 💬 Axitinib [1] 34 💬
75 Pathways in cancer 💬
 [1] FLT4 💬 Cediranib 💬 Cediranib [1] 34 💬
76 Pathways in cancer 💬
 [1] FLT4 💬 Cediranib maleate 💬 Cediranib [1] 34 💬
77 Pathways in cancer 💬
 [1] FLT4 💬 Nintedanib esylate 💬 Nintedanib [7] 51, 84, 85, 89, 227, 228, 331 💬
78 Pathways in cancer 💬
 [1] FLT4 💬 Nintedanib 💬 Nintedanib [7] 51, 84, 85, 89, 227, 228, 331 💬
79 Pathways in cancer 💬
 [1] FLT4 💬 Pazopanib hydrochloride 💬 Pazopanib [1] 227 💬
80 Pathways in cancer 💬
 [1] FLT4 💬 Sorafenib tosylate 💬 Sorafenib [2] 34, 86 💬
81 Pathways in cancer 💬
 [1] FLT4 💬 Sorafenib 💬 Sorafenib [2] 34, 86 💬
82 Pathways in cancer 💬
 [1] FLT4 💬 Sunitinib malate 💬 Sunitinib [2] 28, 34 💬
83 Pathways in cancer 💬
 [1] FLT4 💬 Sunitinib 💬 Sunitinib [2] 28, 34 💬
84 Pathways in cancer 💬
 [1] FLT4 💬 Tesevatinib 💬 Tesevatinib [1] 67 💬
85 PI3K-Akt signaling pathway 💬
 [1] FLT4 💬 Catequentinib 💬 Anlotinib [1] 85 💬
86 PI3K-Akt signaling pathway 💬
 [1] FLT4 💬 Axitinib 💬 Axitinib [1] 34 💬
87 PI3K-Akt signaling pathway 💬
 [1] FLT4 💬 Cediranib 💬 Cediranib [1] 34 💬
88 PI3K-Akt signaling pathway 💬
 [1] FLT4 💬 Cediranib maleate 💬 Cediranib [1] 34 💬
89 PI3K-Akt signaling pathway 💬
 [1] FLT4 💬 Nintedanib esylate 💬 Nintedanib [7] 51, 84, 85, 89, 227, 228, 331 💬
90 PI3K-Akt signaling pathway 💬
 [1] FLT4 💬 Nintedanib 💬 Nintedanib [7] 51, 84, 85, 89, 227, 228, 331 💬
91 PI3K-Akt signaling pathway 💬
 [1] FLT4 💬 Pazopanib hydrochloride 💬 Pazopanib [1] 227 💬
92 PI3K-Akt signaling pathway 💬
 [1] FLT4 💬 Sorafenib tosylate 💬 Sorafenib [2] 34, 86 💬
93 PI3K-Akt signaling pathway 💬
 [1] FLT4 💬 Sorafenib 💬 Sorafenib [2] 34, 86 💬
94 PI3K-Akt signaling pathway 💬
 [1] FLT4 💬 Sunitinib malate 💬 Sunitinib [2] 28, 34 💬
95 PI3K-Akt signaling pathway 💬
 [1] FLT4 💬 Sunitinib 💬 Sunitinib [2] 28, 34 💬
96 PI3K-Akt signaling pathway 💬
 [1] FLT4 💬 Tesevatinib 💬 Tesevatinib [1] 67 💬
97 Rap1 signaling pathway 💬
 [1] FLT4 💬 Catequentinib 💬 Anlotinib [1] 85 💬
98 Rap1 signaling pathway 💬
 [1] FLT4 💬 Axitinib 💬 Axitinib [1] 34 💬
99 Rap1 signaling pathway 💬
 [1] FLT4 💬 Cediranib 💬 Cediranib [1] 34 💬
100 Rap1 signaling pathway 💬
 [1] FLT4 💬 Cediranib maleate 💬 Cediranib [1] 34 💬
101 Rap1 signaling pathway 💬
 [1] FLT4 💬 Nintedanib esylate 💬 Nintedanib [7] 51, 84, 85, 89, 227, 228, 331 💬
102 Rap1 signaling pathway 💬
 [1] FLT4 💬 Nintedanib 💬 Nintedanib [7] 51, 84, 85, 89, 227, 228, 331 💬
103 Rap1 signaling pathway 💬
 [1] FLT4 💬 Pazopanib hydrochloride 💬 Pazopanib [1] 227 💬
104 Rap1 signaling pathway 💬
 [1] FLT4 💬 Sorafenib tosylate 💬 Sorafenib [2] 34, 86 💬
105 Rap1 signaling pathway 💬
 [1] FLT4 💬 Sorafenib 💬 Sorafenib [2] 34, 86 💬
106 Rap1 signaling pathway 💬
 [1] FLT4 💬 Sunitinib malate 💬 Sunitinib [2] 28, 34 💬
107 Rap1 signaling pathway 💬
 [1] FLT4 💬 Sunitinib 💬 Sunitinib [2] 28, 34 💬
108 Rap1 signaling pathway 💬
 [1] FLT4 💬 Tesevatinib 💬 Tesevatinib [1] 67 💬
109 Ras signaling pathway 💬
 [1] FLT4 💬 Catequentinib 💬 Anlotinib [1] 85 💬
110 Ras signaling pathway 💬
 [1] FLT4 💬 Axitinib 💬 Axitinib [1] 34 💬
111 Ras signaling pathway 💬
 [1] FLT4 💬 Cediranib 💬 Cediranib [1] 34 💬
112 Ras signaling pathway 💬
 [1] FLT4 💬 Cediranib maleate 💬 Cediranib [1] 34 💬
113 Ras signaling pathway 💬
 [1] FLT4 💬 Nintedanib esylate 💬 Nintedanib [7] 51, 84, 85, 89, 227, 228, 331 💬
114 Ras signaling pathway 💬
 [1] FLT4 💬 Nintedanib 💬 Nintedanib [7] 51, 84, 85, 89, 227, 228, 331 💬
115 Ras signaling pathway 💬
 [1] FLT4 💬 Pazopanib hydrochloride 💬 Pazopanib [1] 227 💬
116 Ras signaling pathway 💬
 [1] FLT4 💬 Sorafenib tosylate 💬 Sorafenib [2] 34, 86 💬
117 Ras signaling pathway 💬
 [1] FLT4 💬 Sorafenib 💬 Sorafenib [2] 34, 86 💬
118 Ras signaling pathway 💬
 [1] FLT4 💬 Sunitinib malate 💬 Sunitinib [2] 28, 34 💬
119 Ras signaling pathway 💬
 [1] FLT4 💬 Sunitinib 💬 Sunitinib [2] 28, 34 💬
120 Ras signaling pathway 💬
 [1] FLT4 💬 Tesevatinib 💬 Tesevatinib [1] 67 💬

Back to top